Abu Dhabi Investment Authority in Vir Biotechnology, Inc.
Completed. First disclosed October 10, 2019, in a Form 3 (source).
- Investor
- Abu Dhabi Investment Authority (United Arab Emirates)
- Target
- Vir Biotechnology, Inc. (EDGAR CIK 1706431)
- Target country
- United States
- Sector
- Health and Life Sciences (SIC 2836)
- First disclosed
- October 10, 2019, Form 3
- Amount
- Not stated
- Stake at first disclosure
- Not stated
Source Filings and Releases
| Date | Document | Stated stake | Link |
|---|---|---|---|
| October 10, 2019 | Form 3 | Not applicable | View |
| October 18, 2019 | Form 4 | Not applicable | View |
Cite: Middle East Forum, “Abu Dhabi Investment Authority in Vir Biotechnology, Inc.,” Gulf Sovereign Holdings, accessed October 13, 2026, https://statemoney.meforum.org/deal/adia-vir-biotechnology-inc-1706431/.
Gulf money also reaches U.S. universities and lobbyists: the Influence Tracker holds Section 117 gift and contract disclosures and FARA registrations, and the Campus Watch Map places that funding on specific campuses.